Connect with us
European Gaming Congress 2024

Artificial Intelligence

Artificial Intelligence (AI) In Drug Discovery Market Growth Is Driven At A 30% Rate With Increasing Adoption Of Cloud-Based Applications And Services As Per TBRC’s Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022

Published

on

LONDON, May 24, 2022 (GLOBE NEWSWIRE) — According to The Business Research Company’s research report on the artificial intelligence (AI) in drug discovery market, the rising adoption of cloud-based applications and services by pharmaceutical companies will contribute to the growth of AI in the drug discovery market. Among the various end-users of cloud-based drug discovery platforms, pharmaceutical vendors are likely to be major stakeholders, holding a high-value share of the global cloud-based drug discovery platform market. An opportunity analysis of the global market reveals that leading software vendors have already adopted cloud-based drug discovery platforms to facilitate seamless research and development processes. Moreover, the cloud-based drug discovery platform revolution will witness significant growth in the coming years, thereby creating better opportunities for software vendors for growth and expansion. For example, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced in December 2021 that it is collaborating with Pfizer to develop innovative, cloud-based solutions that have the potential to improve how new medicines are developed, manufactured, and distributed for clinical trials. The companies are exploring these advances through their newly created Pfizer Amazon Collaboration Team (PACT) initiative, which applies AWS capabilities in analytics, machine learning, compute, storage, security, and cloud data warehousing to Pfizer laboratory, clinical manufacturing, and clinical supply chain efforts. Thus, the increasing adoption of cloud-based applications and services by pharmaceutical companies will contribute positively to the AI drug discovery market size.

Request for a sample of the global artificial intelligence (AI) in drug discovery market report

The global artificial intelligence in drug discovery market size is expected to grow from $0.79 billion in 2021 to $1.04 billion in 2022 at a compound annual growth rate (CAGR) of 31.6%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The AI in drug discovery market is expected to reach $2.99 billion in 2026 at a CAGR of 30.2%.

Use of AI through Machine Learning (ML) is a trend in assessing pre-clinical studies during the drug development process. Pre-clinical studies are non-clinical studies for novel drug substances to establish clinical efficacy and safety in a controlled environment before testing with a final target population. ML modelling pharmacokinetic (PK) and pharmacodynamic (PD) methodologies are applied in in-vitro and preclinical PK studies to successfully anticipate the dose concentration response relationship of pipeline assets. In addition, deep learning methodologies are employed as ‘In-Silico’ methods for successfully predicting the therapeutic/pharmacological properties of novel molecules by utilizing transcriptomic data, which includes various biological systems and controlled conditions. Besides the drug discovery market, machine learning technology finds its application in the AI in medical diagnostics market as well as AI in medical imaging market.

Major players in the artificial intelligence for drug discovery and development market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica, and BIOAGE.

Advertisement

The global artificial intelligence in drug discovery market report is segmented by technology into deep learning, machine learning; by drug type into small molecule, large molecules; by disease type into metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, others; by end-users into pharmaceutical companies, biopharmaceutical companies, academic and research institutes, others.

In 2021, North America was the largest region in the artificial intelligence (AI) in drug discovery market. It was followed by the Asia-Pacific, Western Europe, and then the other regions. The regions covered in the AI in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provide artificial intelligence (AI) in drug discovery market overviews, artificial intelligence (AI) in drug discovery market analyze and forecast market size and growth for the whole market, artificial intelligence (AI) in drug discovery market segments and geographies, artificial intelligence (AI) in drug discovery market trends, artificial intelligence (AI) in drug discovery market drivers, artificial intelligence (AI) in drug discovery market restraints, artificial intelligence (AI) in drug discovery market leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Not the market you are looking for? Check out some similar market intelligence reports:

Advertisement

AI In Pharma Global Market Report 2022 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research And Development, Epidemic Prediction) – Market Size, Trends, And Global Forecast 2022-2026

Artificial Intelligence In Healthcare Global Market Report 2022 – By Offering (Hardware, Software), By Algorithms (Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing), By Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis), By End User(Hospitals And Diagnostic Centers, Pharmaceutical And Biopharmaceutical Companies, Healthcare Payers, Patients) – Market Size, Trends, And Global Forecast 2022-2026

Cloud Services Global Market Report 2022 – By Type (Software As A Service (SaaS), Platform As A Service (PaaS), Infrastructure As A Service (IaaS), Business Process As A Service (BPaaS)), By End-User Industry (BFSI, Media And Entertainment, IT And Telecommunications, Energy And Utilities, Government And Public Sector, Retail And Consumer Goods, Manufacturing), By Application (Storage, Backup, And Disaster Recovery, Application Development And Testing, Database Management, Business Analytics, Integration And Orchestration, Customer Relationship Management), By Deployment Model (Public Cloud, Private Cloud, Hybrid Cloud), By Organization Size (Large Enterprises, Small And Medium Enterprises) – Market Size, Trends, And Global Forecast 2022-2026

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Advertisement

The World’s Most Comprehensive Database

The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Xinhua Silk Road: E China’s Changzhou City unveils investment opportunities in sectors of new productive forces for global investors

Published

on

xinhua-silk-road:-e-china’s-changzhou-city-unveils-investment-opportunities-in-sectors-of-new-productive-forces-for-global-investors

BEIJING, Sept. 29, 2024 /PRNewswire/ — Changzhou City, an leading international smart manufacturing base located in east China’s Jiangsu Province, has released a bunch of investment investment opportunities to global investors in various sectors of new productive forces at the the 2024 New Energy Industry Development Conference & Invest in Changzhou Conference held in the city on September 19.

The investment opportunities covers nine areas including synthetic biology, low-altitude economy, intelligent connected new energy vehicles, solid-state batteries, hydrogen energy, third-generation semiconductors, and artificial intelligence, manifesting the confidence of Changzhou in further opening development. 
Changzhou, seated in the axis of the Yangtze River Delta, has become an important base for advanced manufacturing in China.
In recent years, thanks to intensified efforts in developing new energy industry and fostering new quality productive forces, Changzhou has expanded the added value of its industrial sector to more than two trillion yuan, with manufacturing added value accounting for about 43 percent, both ranking among the top three in Jiangsu Province.
In the Hurun China New Energy Cities 2024, a list released by the Hurun Research Institute at the conference, Changzhou ranked first among other cities in the country for three consecutive years in terms of investment attractiveness and concentration.
Changzhou has accumulated a total of 10.59 billion US dollars (nearly 74.25 billion yuan) in terms of actually utilized foreign capital since 2020. Major projects such as soft magnetism of ArcelorMittal and medical device of BIOS, a Hong Kong-based company, have been launched during the conference. 
In addition, Changzhou has released a multilingual guide for foreign nationals in Changzhou at the conference, which includes practical service items in stay and residence, work, convenient payment options, among others, turning the city into a more open and international place.
Original link: https://en.imsilkroad.com/p/342380.html
Photo – https://mma.prnewswire.com/media/2518604/Changzhou.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/xinhua-silk-road-e-chinas-changzhou-city-unveils-investment-opportunities-in-sectors-of-new-productive-forces-for-global-investors-302261868.html

Continue Reading

Artificial Intelligence

CGTN: China honors individuals with highest awards in celebration of 75th National Day

Published

on

cgtn:-china-honors-individuals-with-highest-awards-in-celebration-of-75th-national-day

BEIJING, Sept. 29, 2024 /PRNewswire/ — Huang Zongde enlisted in the Chinese People’s Liberation Army at the age of 17, beginning a nearly four-decade-long military career where his bravery, valor and devotion earned him countless awards and honors.

The heavily decorated 93-year-old received the highest state honor on Sunday when Chinese President Xi Jinping conferred him with the Medal of the Republic at a ceremony in the Great Hall of the People in Beijing.
China awarded national medals and national honorary titles to 15 individuals, including Huang, in recognition of their contribution and achievement as it celebrates the 75th anniversary of the founding of the People’s Republic of China, which falls on October 1.
Chinese heroes and role models
In addition to Huang, three others were awarded the Medal of the Republic. Wang Yongzhi, a missile and rocket expert and a pioneer of China’s manned space program, was honored posthumously. Wang Zhenyi, a medical scientist known for breakthroughs in leukemia treatment, and Li Zhensheng, an expert in wheat breeding, are also among the honorees.
The national honorary titles went to 10 people, including scientists, a border patrolman, an artist, a craftsman, educators, a health worker, an economist and an athlete.
Addressing Sunday’s awarding ceremony, President Xi, also general secretary of the Communist Party of China Central Committee and chairman of the Central Military Commission, called on the Chinese people to learn from heroes and role models to form a mighty force to build a strong China.
China is in a crucial period for building a great modern socialist country in all respects and achieving national rejuvenation through Chinese modernization, he said.
Encouraging the Chinese people to strive for extraordinary achievements at ordinary job posts, Xi urged them to contribute to resolving challenges to development and reform and safeguarding social harmony and stability.
China’s old friends and good friends
As its highest state honor for foreigners, China awarded the Friendship Medal to Dilma Rousseff, president of the New Development Bank and former Brazilian president, for her commitment to the friendship between China and Brazil, and development of relationship between China and the Community of Latin American and Caribbean States, and cooperation among BRICS countries, a group of major emerging economies.
Accepting the honor at the ceremony, Rousseff said the medal symbolizes the strong bonds between Brazil and China and pledged to continue her unremitting efforts to promote the friendship.
China’s achievements over the decades, including economic transformation, technological innovation and remarkable social development, have made it a beacon and a source of inspiration for the world, she said.
Xi lauded Rousseff as an outstanding representative of China’s old friends and good friends who have shared the same aspirations and stood together with the Chinese people over the past 75 years and vowed that China will never forget such international friends.
The Chinese people are ready to join hands with people from all over the world to safeguard world peace, promote common development and advance the building of a community with a shared future for mankind to create a better future for humanity, he said.
https://news.cgtn.com/news/2024-09-29/China-honors-individuals-with-highest-awards-ahead-of-National-Day-1xhS1SaZeZa/p.html
 

View original content:https://www.prnewswire.co.uk/news-releases/cgtn-china-honors-individuals-with-highest-awards-in-celebration-of-75th-national-day-302261867.html

Continue Reading

Artificial Intelligence

Kazakhstan Government Delegation Visited SUPCON

Published

on

kazakhstan-government-delegation-visited-supcon

HANGZHOU, China, Sept. 29, 2024 /PRNewswire/ — On September 26, a delegation from the Ministry of Digital Development, Innovations and Aerospace Industry of the Republic of Kazakhstan, led by Minister Madiyev Zhaslan, visited SUPCON. SUPCON’s Chairman and President, Mr.Cui Shan, warmly welcomed the delegation.

The Kazakhstan government representatives expressed their appreciation and recognition of SUPCON’s expertise and innovation in intelligent manufacturing, digital transformation, and industrial AI.
Madiyev Zhaslan expressed a strong interest in industrial AI technologies of SUPCON, particularly their applications in intelligent and low-carbon facilities. He looks forward to exploring extensive collaboration with SUPCON across various sectors in Kazakhstan.
Cui Shan emphasized that as a leading industrial AI company with a global presence, SUPCON will leverage its technological advantages to meet Kazakhstan’s industry development requirements and trends, injecting new momentum into the country’s industrial digitalization.
In 2023, SUPCON established a subsidiary in Kazakhstan as its Central Asia regional headquarters and set up a localized operational system. SUPCON will continue to invest in the long-term development of the Central Asia region, contributing further wisdom and strength to the industrial digital transformation in Kazakhstan and beyond.
Photo – https://mma.prnewswire.com/media/2518470/image_5022684_18905906.jpg Photo – https://mma.prnewswire.com/media/2518471/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/kazakhstan-government-delegation-visited-supcon-302261857.html

Continue Reading

Trending